A -- LINEAR ARRAY

The Centers for Disease Control and Prevention (CDC) plans to issue a sole source purchase order to Roche Diagnostics Corporation for a Linear Array HPV Genotyping Test, which is uniquely capable of identifying and genotyping individual human papillomavirus types linked to cervical cancer. This procurement is justified under federal acquisition regulations that allow for sole source contracting when only one responsible provider can meet the agency’s needs. As such, no competitive solicitation will be issued, and the CDC has indicated that no other vendors can fulfill this specific requirement. Interested parties may express their interest and capabilities, but this information will only be used for informational purposes and will not lead to a solicitation. This acquisition is not designated as a small business set-aside. For any contractual questions, Beth West, the designated procurement technician at the CDC, is the primary point of contact. The arrangement underscores the unique nature of the product and the CDC’s reliance on Roche Diagnostics as the exclusive provider for this critical testing technology.